Kendral-Ipratropium en es it fr

Kendral-Ipratropium Brand names, Kendral-Ipratropium Analogs

Kendral-Ipratropium Brand Names Mixture

  • Combivent Inhalation Aerosol (Ipratropium Bromide + Salbutamol Sulfate)
  • Combivent Inhalation Solution (Ipratropium Bromide + Salbutamol Sulfate)
  • Duovent Udv (Fenoterol Hydrobromide + Ipratropium Bromide)
  • Ratio-Ipra Sal Udv (Ipratropium Bromide + Salbutamol Sulfate)

Kendral-Ipratropium Chemical_Formula


Kendral-Ipratropium RX_link

Kendral-Ipratropium fda sheet

Kendral-Ipratropium FDA

Kendral-Ipratropium msds (material safety sheet)

Kendral-Ipratropium Synthesis Reference

K. Zeile et al.,U.S. Pat. 3,505,337 (1970)

Kendral-Ipratropium Molecular Weight

332.457 g/mol

Kendral-Ipratropium Melting Point


Kendral-Ipratropium H2O Solubility

Freely soluble

Kendral-Ipratropium State


Kendral-Ipratropium LogP

No information avaliable

Kendral-Ipratropium Dosage Forms

Aerosol (with propellants); Liquid; Metered-dose (aerosol); Metered-dose (pump); Solution

Kendral-Ipratropium Indication

For maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema.

Kendral-Ipratropium Pharmacology

Ipratropium bromide, a synthetic ammonium compound structurally similar to atropine, is used as a bronchodilator in the management of cholinergic-mediated bronchospasm associated with chronic obstructive pulmonary disease and in the treatment of rhinorrhea associated with the common cold or with allergic or nonallergic seasonal rhinitis.

Kendral-Ipratropium Absorption

Inhalation (local)-minimal; Nasal-rapid and minimal

Kendral-Ipratropium side effects and Toxicity

LD50=1001mg/kg (orally in mice)

Kendral-Ipratropium Patient Information

Kendral-Ipratropium Organisms Affected

Humans and other mammals